in the FKBP5 gene was genotyped using Infinium PsychArray Bead Chips. Results and Conclusion: SCZ and BD patients performed lower than HC in the TMT-A&B and in the Digit-span backwards task, while no differences were observed between SCZ and BD patients. While SCZ patients performed lower than HC in the Digit-span forwards task, there were no differences between BD and HC or between BD and SCZ. Rs 3800373 was not associated with performance in the TMT-A&B or Digit-span forwards&backwards tasks. SCZ and BD share largely overlapping neurocognitive characteristics. Rs3800373 was not associated with performance in the neuropsychological tests. However, given the limited sample size, the results do not exclude an association with the rs3800373 variant in a larger sample. Furthermore, as the analysis was limited to one SNP, the results cannot be generalized to other genetic variants in FKBP5.
INTRODUCTION
Schizophrenia (SCZ) and bipolar disorder (BD) are complex disorders with overlapping clinical symptoms and genetic factors. Studies on SCZ and BD have explored genotype-endophenotype relationships (1, 2) ). Research findings have indicated that SCZ and BD overlap both in their clinical symptoms and in certain hereditary features (3), including genetic-molecular risk variants (4) . Further studies have examined the similarities and differences in cognitive impairment, neurophysiology, and damage to certain areas of the brain in SCZ and BD patients (5) . Identifying disease-related genetic variants is one major focus in psychiatric research, with implications for the diagnostic boundaries of disorders and the development of a better psychopharmacological treatment.
Recent studies have shown the influence of specific genetic variations in the FK506 binding protein 5 gene (FKBP5), which codes for the FKBP51 protein. FKBP51 binds heat shock protein 90 (Hsp90) a chaperone of the glucocorticoid receptor. At Hsp90, FKBP51 competes with FKBP52, a homologue of FKBP51. The Hsp90 / glucocorticoid receptor complex bound to FKBP52 is preferentially transferred to the nucleus. In the nuclear compartment, Hsp90 dissociates and the glucocorticoid receptor drives gene expression of ORIGINAL PAPER glucocorticoid-responsive genes. Self-regulation of the glucocorticoid effects on transcription occurs because glucocorticoid receptors also induce FKBP5 gene expression, which in turn leads to a diminished nuclear import of Hsp90-glucocorticoid receptor complexes (6) . By these processes, FKBP51 is thought to affect the sensitivity of glucocorticoid receptors.FKBP5 has been implied in gene-environment interactions for the development of psychiatric disorders (7), e.g. BD (8) and endophenotypes such as impaired cognitive function in SCZ (9) . The hypothalamus-pituitary-adrenal (HPA) axis mediates the stress response through regulation of cortisol. The well-established relationship between the HPA axis and psychotic disorders is consistent with the above mentioned findings. It has been shown that polymorphisms rs3800373, rs9296158, and rs1360780, which are located in close linkage disequilibrium within FKBP5 (see Supplementary information), are associated with increased risk of depression (10) and PTSD (11, 12) , as well as with a better response to antidepressants in patients suffering from depression (13) . Furthermore, rs3800373 has been linked to inadequate normalization of cortisol secretion in healthy individuals after psychosocial stress (12, 14) . In line with this, changes FKBP5 expression in the brains of patients suffering from SCZ and BD were observed (15) . SCZ and BD, however, are comparably broad diagnostic categories. The association findings may therefore be refined by testing for association with more homogeneous groups or with endophenotypes of SCZ and BD. This may increase the understanding of the causal pathways from specific genetic variant to specific disorder and give further insight into the association findings that cross diagnostic boundaries.
Several neuropsychological measures have been suggested as promising endophenotypes to test the genetic underpinnings of SCZ and BD. Notably deficits in working memory,declarative memory and attention deficits (16) (17) (18) (19) (20) (21) have been observed.
AIM
The aim of our research was to explore the degree of cognitive impairment in patients suffering from SCZ and BD. Furthermore we assessed the association of the FKBP5 variant rs3800373 genotype with the cognitive endophenotypes working memory, declarative memory and attention deficits in patients with SCZ and BD and healthy controls(HC).
MATERIAL AND METHODS
The study is a partly prospective clinical and genetic case-control study that took place within a period of two years. 
Neurophysiological assessment Trail Making Test-A&B (TMT-A&B)
The TMT-A&B provides information on executive functions and also visual search, mental flexibility, and speed of processing. The TMT has two parts: TMT-A requires participants to draw lines to connect 25 consecutive numbers; TMT-B requires the same, but requires participants to alternate between consecutive numbers and consecutive letters. The TMT-A&B score represents the time required to complete the task (22, 23) ).
Digit-span test (working memory, HAWIE-R)
Working memory, in particular number storage capacity, was evaluated by the Digit-span (forward & backward) subtest of the Hamburg-Wechsler Adult Intelligence Scale revised (HAWIE-R; Tewes, 1991) (24) . Participants need to repeat verbally presented number sequences (e.g. "7, 2, 9") out loud. If they succeed, the length of the number sequence is increased. In the Digit-span forward task, the subject is asked to repeat the digits in the given order, while in the Digit-span backwards task, the subject needs to reverse the order of the numbers (25) .
Biomarkers Blood sample for DNA extraction From each patient, around 30 ml of peripheral blood was collected in (ethylenediamine tetraacetic acid) EDTA; from inpatients at three time points, and from outpatients and controls at onetime point. DNA was isolated from 10 ml of blood according to the manufactured instructions (QIAamp DNA Blood Maxi Kit, Qiagen, Germantown, MD, USA). DNA was eluted from the column three times with 1 ml of buffer provided by the manufacturer. The DNA isolation and blood storage was done at the Laboratory for Cytogenetics and Molecular Diagnostics, Department of Pathology, Clinical Centre of the University of Sarajevo.
Genotyping and quality control All subjects were genotyped using the Illumina Infinium Psych Array Bead Chip (Illumina Inc., San Diego). Quality control was carried our using the software PLINK (http://pngu.mgh.harvard.edu/purcell/plink/). In brief, the following quality control measures were applied to remove single nucleotide polymorphisms (SNPs): call rate <0.98; minor allele frequency <0.01; and Hardy Weinberg Disequilibrium p<10 -6 . Subjects were removed if they fulfilled the following criteria: call rate <0.98; duplicated or cryptic relatedness; and outliers on the first 10 principal components (26) .The SNP rs3800373 in the FKBP5 gene was selected for analy- (Table 1) .
RESULTS

Analysis of performance in TMT-
Rs3800373 was not significantly associated with BD, χ 2 (1) = .10, p = .784 (Table 2) . Rs3800373 was not significantly associated with SCZχ 2 (1) = .97, p = .326 (Table 3) 
DISCUSSION
The endopheno types investigated in this study all belong to cognition. Cognitive capability is a complex hereditary trait shaped by a great number of genes, all with relatively weak and variable influence on the cognitive phenotype of an individual. It is well-known that general cognitive capability is an individually variable but also a highly hereditary trait (27) . In our results, both SCZ and BD patients needed more time to complete the TMT-A&B compared to the HC. There was no difference between BD and SCZ patients, which is in line with the results of other studies (28) (29) (30) (34, 35) . Working memory and executive cognition is compromised in patients with SCZ and BD (36) . In our study, we observed an association of working memory with SCZ and BD diagnosis. Digit-span forward & backward tasks are used to measure working memory's storage capacity. In our study, SCZ patients performed significantly lower than controls in the forward digit-span task. However, there was no difference between BD vs HC or between BD vs SCZ patients. In the backwards digit-span task, both SCZ and BD patients performed significantly lower than HC, while there was no difference between BD and SCZ patients. Our results are in line with previous studies which showed no group differences between SCZ and BD patients in different working memory measures (37, 38) , although our findings are not unequivocal, as another study found more severe deficits in working memory in SCZ than in BD patients (33) .
In our study, we tested the association between the FKBP5SNP rs3800373 and categorical diagnosis, working memory, declarative memory and attention. However, no association was found. While former studies have reported a lack of association of rs3800373 with affective disorder and psychotic disorder (38, 39) , as well as cognitive performance (38, 40) , there are also a series of studies that have reported a positive association between the rs3800373 variant and a diagnosis of depression (12), higher depression ratings (41), suicide attempts (34, 35, 42) , response to medication, and course of disorder (43) .
Two major limitations of our study are that, due to the small sample size, we i.) neither included the treatment in our analyses nor ii.) tested for specific clinical features such as psychotic symptoms. Apart from the above mentioned main limitation of our genetic association study -the small sample size -the focus on a single candidate SNP is another limitation.
CONCLUSION
This study investigated the role of the FKBP5 variant rs3800373 in cognitive impairment in different neuropsychological measures, the TMT-A&B and Digit-span forwards & backwards, within the groups of BD and SCZ. The finding that SCZ as well as BD are distinct from controls with respect to most endophenotype measures of cognitive impairment is in line with previous findings and can be seen as a quality measure for the assessment of the present sample. The fact that no genetic association could be found with variation in the candidate gene FKBP5, neither with diagnosis nor with cognitive endophenotype, does not rule out that those associations may be seen with larger samples.
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